‘‘(v) organizations representing pa-
tients. 
‘‘(3) COMPOSITION OF BOARD.—The member-
ship of the Board may not exceed 21 individuals, all 
of whom shall be voting members. The Board shall 
be composed of the following: 
‘‘(A) The Director of NIH, who shall be a 
permanent member on an ex officio basis. 
‘‘(B) Not fewer than 9 officials who are di-
rectors of national research institutes or na-
tional centers. The Secretary shall designate 
such officials for membership and shall ensure 
that the group of officials so designated in-
cludes directors of—
‘‘(i) national research institutes whose 
budgets are substantial relative to a major-
ity of the other institutes; 
‘‘(ii) 
national 
research 
institutes 
whose budgets are small relative to a ma-
jority of the other institutes; 
‘‘(iii) national research institutes that 
have been in existence for a substantial pe-
riod of time without significant organiza-
tional change under subsection (d);
‘‘(iv) as applicable, national research 
institutes that have undergone significant 
organization changes under such sub-
section, or that have been established 
under such subsection, other than national 
research institutes for which such changes 
have been in place for a substantial period 
of time; and 
‘‘(v) national centers. 
‘‘(C) Members appointed by the Secretary 
from among individuals who are not officers or 
employees of the United States. Such members 
shall include—
‘‘(i) individuals representing the inter-
ests of public or private institutions of 
higher education that have historically re-
ceived funds from NIH to conduct re-
search; and 
‘‘(ii) individuals representing the in-
terests of private entities that have re-
ceived funds from NIH to conduct research 
or that have broad expertise regarding how 
the National Institutes of Health func-
tions, exclusive of private entities to which 
clause (i) applies.
‘‘(4) CHAIR.—The Chair of the Board shall be 
selected by the Secretary from among the appointed 
members of the Board, except that the Secretary 
may select the Director of NIH as the Chair. The 
term of office of the Chair shall be 2 years. 
‘‘(5) MEETINGS.—
‘‘(A) IN GENERAL.—The Board shall meet 
at the call of the Chair or upon the request of 
the Director of NIH, but not fewer than 5 
times with respect to issuing any particular re-
port under paragraph (2)(A). The location of 
the meetings of the Board is subject to the ap-
proval of the Director of NIH. 
‘‘(B) PARTICULAR FORUMS.—Of the meet-
ings held under subparagraph (A) with respect 
to a report under paragraph (2)(A)—
‘‘(i) one or more shall be directed to-
ward the scientific community to address 
scientific needs and opportunities related 
to proposals for organizational changes 
under subsection (d), or as the case may 
be, related to a proposal that no such 
changes be made; and 
‘‘(ii) one or more shall be directed to-
ward consumer organizations to address
the needs and opportunities of patients 
and their families with respect to proposals 
referred to in clause (i). 
‘‘(C) 
AVAILABILITY
OF
INFORMATION 
FROM FORUMS.—For each meeting under sub-
paragraph (B), the Director of NIH shall post 
on the Internet site of the National Institutes 
of Health a summary of the proceedings. 
‘‘(6) COMPENSATION; TERM OF OFFICE.—The 
provisions of subsections (b)(4) and (c) of section 
406 apply with respect to the Board to the same ex-
tent and in the same manner as such provisions 
apply with respect to an advisory council referred to 
in such subsections, except that the reference in 
such subsection (c) to 4 years regarding the term of 
an appointed member is deemed to be a reference to 
5 years. 
‘‘(7) REPORTS.—
‘‘(A) 
RECOMMENDATIONS
FOR 
CHANGES.—Each 
report 
under 
paragraph 
(2)(A) shall be submitted to—
‘‘(i) the Committee on Energy and 
Commerce within the House of Represent-
atives;